Non invasive near infrared fluorescence imaging of mice models is a very attractive tool for fastening the development of new therapeutics. Two classes of labels exist for the near infrared domain: organic dyes and quantum dots (QDs). QDs are inorganic luminescent semi-conductor nano-crystals which display very attractive optical features. They are now commercially available for in vivo mouse tests, and new compositions with less toxic elements are currently being developed.
INTRODUCTION
The impact of non invasive imaging in small animal models such as rodents is increasingly growing for the development of new therapies [1, 2] . Fluorescence is an imaging modality that offers a good sensibility whenever a few centimeters of tissues are observed, that does not use ionizing radiations, and has a low instrumentation cost. The development of new optical probes for imaging a variety of biological processes is therefore needed.
These optical probes are designed using labels absorbing and emitting in the near infrared domain, at wavelengths for which light absorption and diffusion by the tissues are minimal. Fluorescent near infrared organic dyes (cyanines for example) or quantum dots are mainly used [3] . Quantum dots (QDs) are inorganic semi-conducting nanocrystals. They display optical properties that can be superior to those of classical organic dyes, such as improved resistance to photo-bleaching and narrow emission spectrum, which wavelength can be set according to the particle size and composition [4] . Moreover, whereas visible quantum dots contain heavy atoms (Cd, Te, Se…), new compositions containing less toxic elements have been proposed and are currently developed for the near infrared domain [5] . The functionalization of these objects has also been intensively developed in the last few years, in order to avoid any heavy atom leak and allow water solubilization and biomolecule grafting onto the particles [6, 7] . Therefore, several imaging demonstrations in animals have been performed in the last few years. Bawendi, Frangioni et al. have imaged sentinel lymph nodes in pig using phosphine coated infrared quantum dots injected at cadmium doses lower than the rat LD50 [8] . The group of Nie has targeted prostate cancer cells in mouse using visible quantum dots coated by a tri-block copolymer, conferring the nanoparticles a good in vivo furtivity and allowing their functionalization by tumor-directed antibodies [9] . Therefore, these nano-particles can be envisioned as very promising labels, at least for animal imaging applications.
The concept of activatable probe is also another breakthrough in the domain of contrast agents for in vivo imaging [10, 11] . An activatable probe is composed of a near infrared emitting label linked to a fluorescence inhibitor via a cleavable chemical bond. The probe is initially non fluorescent due to the spatial proximity between the label and the inhibitor, and its fluorescence is activated by the breaking of the cleavable bound. For example, the group of Weissleder and Tung developed a series of activatable probes dedicated to in vivo enzymatic activity imaging [11] [12] [13] . More recently, we designed cRGD molecular probes for tumor targeting and cell internalization imaging [14] [15] [16] . The use of such activatable probes increases the fluorescence signal ratio between healthy and tumor tissues, and therefore the image contrast.
Activatable probes based on quantum dots as near infrared labels should therefore conjugate both the optical benefits of the QD nano-particles, and the improved contrast brought by fluorescence activation. The construction of such activatable quantum dot probes has been undertaken. Organic cleavable spacers X-L-S-S-L'-I in which S-S is a disulfide bond cleavable by cell internalization [15, 16] , I an organic quencher of quantum dot fluorescence, and X a chemical group for QD grafting, have been synthesized. The functionalization of the QD by 12 such cleavable spacers leads to more than 85% fluorescence inhibition, which can be recovered upon cleavage of the disulfide bonds.
EXPERIMENTAL

Materials and methods
CdTe/ZnS ITK705-amino-(PEG) quantum dots (reference Q21561MP) are purchased from Invitrogen, Cy7Q and QSY21 in their acid N-hydrosuccinimide ester form respectively from GE Healthcare and Invitrogen. Other organic products and solvents come from Sigma-Aldrich (France). Electrospray (ESI) mass spectra are recorded in positive mode using an ionic trap LCQ spectrometer (Finnigann). 1 H and 13 C NMR spectra are recorded in CD 3 OD on a Bruker Avance 200 spectrometer. HPLC purification and analysis of the quencher labeled organic spacers X-L-S-S-L'-I are performed on a Waters equipment, composed of an Alliance 2695 controller and a Waters 2695 UV detector. A Supelcosyl LC-318 column (Supelco 300 Å 5 µm C 18 particles, 50 x 4.6 mm) and a gradient of acetonitrile and TEA-AcOH solution (0.2 M) are used for separation. Absorption and fluorescence spectra are recorded respectively using a Varian Cary 300 spectrometer and a Perkin Elmer LS50B fluorimeter. Particle hydrodynamic diameter in solution is measured using a Zetasizer Nano (Malvern Instruments). Whole-body Fluorescence Reflectance Imaging (FRI) of anesthetized Nude Swiss mice (6-8 weeks old, Iffa-Credo) is carried out on an experimental set-up which has been described elsewhere [17] .
Synthesis of the X-S-S-I organic cleavable spacers
The synthesis scheme of the X-L-S-S-L'-I organic cleavable spacer 5, as well as its coupling reaction with ITK705-amino (PEG) quantum dots, are represented in Figure 1 . Since organic quenchers are mostly available as the amine-reactive acid N-hydrosuccinimide ester form, the commercial cystamine 1, containing both a disulfide bond and amino groups, is used as starting material. Direct attachment of the amino-bearing organic cleavable spacer to carboxylic-acid functionalized quantum dots, available commercially from Invitrogen, could have been undertaken. However, ITK705-carboxylic acid quantum dots (reference Q21361MP) are not entrapped in a PEG coating as ITK705-amino (PEG) quantum dots (reference Q21561MP). Since this PEG coating is necessary to the in vivo furtivity of the nanoparticles (see § 3.1.), we preferred to use PEG coated ITK705-amino (PEG) quantum dots 6, which amino functions are transformed easily into maleimide groups using the 4-maleimidobutyric acid N-hydrosuccinimide ester cross-linker 10, to lead to ITK705-maleimido (PEG) quantum dots 7 [18] . Boc-mono-protection of 1 leading to compound 2 is used in order to graft only one thioacetate group per linker (compound 3) for further reaction with the maleimide functions of the QD. Boc deprotection of 3 leads to compound 4, which can be derivatized with an organic fluorescence quencher, such as Cy7Q, to lead to the X-L-S-S-L'-Cy7Q organic cleavable spacer 5.
Synthesis of 2 (Boc mono-protected cystamine)
. Cystamine 1 (1 g) is dissolved in 100 mL dioxane:water 1:1, then stirred with sodium hydrogenocarbonate (1.38 g) and di-tert-butyl dicarbonate (1 mL) overnight. After chromatographic purification on silica, the Boc-mono protected cystamine 2 is obtained (35%). 
Coupling of the fluorescence inhibitors or the organic cleavable spacers 5 to the quantum dots
ITK705 amino (PEG) quantum dots are either directly grafted with acid N-hydrosuccinimide ester fluorescence inhibitors, or derivitized by maleimide groups for coupling with the organic cleavable spacer 5.
Grafting of acid N-hydrosuccinimide ester fluorescence inhibitors onto ITK705 amino (PEG) quantum dots.
According to the protocol furnished by the supplier, ITK705 amino-quantum dots (0.6 nmol) are transferred in PBS buffer, incubated 2 hours at room temperature in dark in the presence of either Cy7Q or QSY21 in their acid Nhydrosuccinimide ester form (100 nmol), then purified using NAP G-25 micro-columns (Amersham Biosciences). Synthesis of ITK705 maleimido (PEG) quantum dots 7. ITK705 maleimido (PEG) quantum dots 7 are obtained following the procedure already described in the literature [18] . Briefly, ITK705 amino (PEG) quantum dots 6 (0.6 nmol) are transferred in PBS buffer, incubated 3 hours at room temperature in dark in the presence of 4-maleimidobutyric acid Nhydrosuccinimide ester 10 (0.6 µmol), then purified using NAP G-25 micro-columns (Amersham Biosciences). Coupling of ITK705 maleimido (PEG) quantum dots 7 and the organic cleavable spacer 5. ITK705 maleimido (PEG) quantum dots 7 (0.2 nmol) are incubated 4 hours at room temperature in dark in the presence of the organic cleavable spacers 5 (5 nmol), then purified using NAP G-25 micro-columns (Amersham Biosciences). Gel electrophoresis. Surface modification of quantum dots is evidenced by absorption and fluorescence spectroscopy, along with agarose (1%) gel electrophoresis, carried out at 100 V in a TAE buffer pH 8. Gels are observed using either UV absorption analysis at 254 nm, or fluorescence analysis using a whole-body mouse fluorescence reflectance imaging device exciting at 633 nm and collecting fluorescence at wavelengths superior to 700 nm [17] .
RESULTS AND DISCUSSION
Choice of suitable quantum dots
The activatable quantum dot probes we designed are based on ITK705-amino (PEG) particles (In Vitrogen, reference Q21561MP). These particles are 705 nm emitting CdTe/ZnS quantum dots, coated by a polymer and 2,000 Da weight poly-ethylene-glycol (PEG) chains, bearing at their extremity primary amino groups. Direct attachment of the amino-bearing organic cleavable spacer to carboxylic-acid functionalized quantum dots, available commercially (reference Q21361MP Invitrogen), could have been undertaken (see above § 2.2). However, ITK705-carboxylic acid quantum dots are not entrapped in a PEG coating as ITK705-amino (PEG) quantum dots (reference Q21561MP, Invitrogen). It has been observed that such a PEG coating with chains from 2,000 to 5,000 Da was necessary in order to confer the particles high blood circulation times, which is necessary for their tumor targeting after intra-venous injection [9, 19] . Injection of non PEGylated quantum dots or quantum dots PEGylated by low molecular weight chains (750 Da) leads to massive accumulation of the nano-particles in the animal liver (Figure 2 ). The amino groups (around 80 to 100 per 20 nm diameter particle [18] ) pendant on the extremity of the PEG chains coating the ITK705 amino (PEG) quantum dots, can be used for grafting either a tumor-targeting ligand (such as the cRGD peptide targeting the endothelial cells of angiogenic blood vessels invading tumours [14, 15, 18] ), or a cleavable spacer bearing at its extremity a fluorescence inhibitor, or both. and purified. B. 705 nm-emitting quantum dots (Q21061MP, Invitrogen), coated by a PEG 5000 polymer.
QD705-PEG
Inhibition of the quantum dot fluorescence by organic quenchers
The design of biosensors using Fluorescence Energy Transfer (FRET) between visible light emitting quantum dots acting as either energy donors or acceptors, and organic dyes grafted on their surface, has already been described [4, 20] . In the present study, near infrared emitting quantum dots are used as energy donors, whereas non emissive organic quenchers act as acceptors. These organic quenchers must be chosen so that their absorption spectrum matches the emission band of the 705 nm emitting quantum dots. Few organic quenchers are commercially available in the near infrared domain. The Cy7Q cyanine (Amersham) as well as the QSY21 diarylrhodamine (Initrogen) are non emissive dyes, which absorption spectra well overlap with that of the emission spectrum of the ITK 705 amino (PEG) quantum dots ( Figure 3A and B) .
Simple mixing in solution of the ITK 705 amino (PEG) quantum dots with increasing concentrations of the two quenchers already leads to efficient fluorescence quenching, as demonstrated by the Stern-Volmer plots of Figure 3C . These plots display the ratio Φ 0 /Φ against the fluorescence quencher concentration, in which Φ 0 and Φ are the respective fluorescence quantum yields of the quantum dots alone and in the presence of the quencher.
Two hour incubation of a 160 fold excess of the acid N-hydrosuccinimide ester form of these quenchers in the presence of ITK 705 amino (PEG) quantum dots, followed by chromatographic purification, leads to the grafting of 0 Jo KfXON9 around 80 fluorescence inhibitors per particle (over the 80 to 100 amino groups available), as quantitated by absorption spectroscopy. The grafting of the quenchers onto the particle surface accelerates the electrophoretic migation of the quantum dots towards the positive electrode on agarose gel in TAE buffer pH 8.0, evidencing surface modification of the QDs. The direct grafting of these 80 fluorescence inhibitors on the amino groups leads to a very efficient fluorescence inhibition of the quantum dots (more than 99%), for both the hydrophilic negatively charged inhibitor (Cy7Q) and the hydrophobic inhibitor (QSY21) (Figure 3D) , demonstrating therefore the concept of activatable probes based on quantum dots as emitting labels. 
Functionalization of the particles in order to design activatable probes
Organic spacers X-L-S-S-L'-Cy7Q, including a disulfide bond S-S which is cleavable upon cellular internalization [14] [15] [16] , a X group for grafting to the QD particle, and the fluorescence inhibitor Cy7Q, have therefore been designed and synthesized (see § 2.2). In order to control the coupling of the organic spacer X-L-S-S-L' to both the Cy7Q organic quencher available as an acid N-succinimide ester, and the ITK705 amino (PEG) quantum dots, with orthogonal biocompatible chemistries, the QDs are derivatized with maleimido groups, and the thioacetate function is chosen as the X group. Easy coupling of ITK705 maleimido (PEG) quantum dots 7 with thioacetate bearing ligands has been previously demonstrated [18] . Indeed, maleimide derivatization of the ITK705 amino (PEG) quantum dots 6 and their further functionalization by X-L-S-S-L'-Cy7Q is evidenced by gel electrophoresis (Figure 4 ). All particles migrate towards the positive electrode, certainly because of the negative charges beard by the polymer coating the nano-particles. The replacement of the amino-groups, positively charged as ammonium functions at pH 8, by neutral maleimide groups increases the mobility of the particles. The grafting of the X-L-S-S-L'-Cy7Q organic spacers, containing negatively charged Cy7Q further favors QD migration towards the positive pole. It is noticeable that the QDs 8 functionalized by the X-L-S-S-L'-Cy7Q organic spacers 5 can only be visualized on gel using UV absorption ( Figure 4A ) but not fluorescence detection ( Figure 4B ). Particle hydrodynamic diameter in PBS solution (10 mM, pH 7.4) measured using Dynamic Light Scattering ((DLS) remains the same before and after the grafting of the organic cleavable spacers (20 ± 1 nm), since these functional groups are quite short carbon chains (10 atoms). The organic spacers 5 designed in this work are activatable upon cellular internalization, because of the reductive medium of the lysosomal compartment which induces cleavage of the disulfide bond [14] [15] [16] . They are therefore designed to be grafted onto the quantum dot surface along with other tumour-targeting and cell internalization driving ligands, such as the cRGD peptide [14] [15] [16] , in a final tumor imaging application. That is why the demonstration of the feasibility of activatable probes based on ITK705 (PEG) quantum dots and the organic cleavable spacers 5 is made using a quite small ratio of activatable spacers 5 per particle, so that the other maleimido pending groups of quantum dots 7 can be in the future derivatized by both the cell internalization activatable spacers 5, and the cRGD tumourtargeting and internalization ligands [14] [15] [16] .
After 4 hours incubation of a 25 fold excess of organic spacers 5 per ITK705 maleimido (PEG) quantum dots, the number of organic cleavable spacers 5 grafted per particle is quantitated to 12 using absorption spectroscopy ( Figure  5A ). The emission spectra of the ITK705 amino (PEG) quantum dots 6, ITK705 maleimido (PEG) quantum dots 7, and QD-(-L-S-S-L'-Cy7Q) 12 8 are displayed in Figure 5B . The fluorescence emission quantum yields upon 590 nm excitation are measured using Nile Blue perchlorate in ethanol as a reference (fluorescence quantum yield 27% [21] ). Derivatization of the amino (PEG) quantum dots (fluorescence quantum yield of 6: 10 %) by the maleimide groups increases slightly the fluorescence of the particles (fluorescence quantum yield of 7: 13%), whereas the grafting of 12 organic spacers 5 per particle inhibits as expected the QD fluorescence (fluorescence quantum yield of 8: 1.7%). This 87% initial fluorescence inhibition between ITK705 maleimido (PEG) quantum dots and the QD(-L-S-S-L'-Cy7Q) 12 8 is similar to that obtained for other activatable probes based on organic dyes [14] [15] [16] , which improvement of the contrast of tumour images has been demonstrated. Moreover, on particles 8, around 60 to 70 maleimido groups should still be available for derivatization by tumour-targeting ligands in the future. Absorbance (au
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Normalized fluorescence (a.u.) Figure 5 . Photo-physical properties of the ITK705 amino (PEG) quantum dots 6, before and after grafting of 12 cleavable organic spacers X-L-S-S-L'-Cy7Q (nano-particles 8). A. Absorption spectra: the absorption spectrum of QD 8 matches the sum of the absorption spectra of QD 6 + 12 Cy7Q quenchers/particle. B. Emission spectra (excitation 590 nm) of ITK705 amino (PEG) quantum dots 6, ITK705 maleimido (PEG) quantum dots 7, and after grafting of 12 cleavable organic spacers X-L-S-S-L'-Cy7Q/particle (nano-particles 8). Quantum dot concentration is around 0.1 µM in PBS buffer (10 mM, pH 7.4).
Upon the addition of 2-mercaptoethanol (2-MCE), a disulfide bond chemical reducer, to a solution of QD-(-L-S-S-L'-Cy7Q) 12 8, a fluorescence recovery is observed, attributed to the cleavage of the S-S disulfide bound linking the Cy7Q quencher to the nano-particle ( Figure 6A) . A negative control with non functionalized ITK705 amino or maleimido (PEG) quantum dots 6 or 7 displays no fluorescence modification upon 2-MCE addition. This fluorescence recovery is around 100% of that of the fluorescence of ITK705 amino (PEG) quantum dots 6, and 77% of that of the fluorescence of the ITK705 maleimido (PEG) quantum dots 7. It is still unclear whether this final fluorescence level is accounted for: (1) non total disulfide bond cleavage; (2) a fluorescence quantum yield for the ITK705 thio (PEG) quantum dots (QD(-L-SH) 12 ) obtained after disulfide bond cleavage similar to that of amino (PEG) quantum dots 6 and lower than that of maleimido (PEG) quantum dots 7; (3) a fluorescence quenching of the ITK705 thio (PEG) quantum dots by the diffusing cleaved quenchers HS-L'-Cy7Q, comparable to what is observed in Figure 3C . However, hypothesis (2) and/or (3) seem the more relevant, since the 2-MCE reducer was added in over excess (70 mM against 0,1 µM quantum dots 8), and the diffusing cleaved quenchers HS-L'-Cy7Q concentration (around 1 µM) effectively corresponds to a ≈ 25% fluorescence quenching of the nano-particles in Figure 3C .
Fluorescence recovery was fitted using a 1 rst order kinetics model ( Figure 6B ), using Equation (1):
in which I(t = 0), I(t) and I(t = ∞) represent respectively the fluorescence levels before addition of 2-MCE, at time t, and extrapolated at time infinite. Two regimes are observed: a very short one, with a time constant τ 1 = 5.6 min; and a second one, quite long, which a time constant τ 2 = 143 min. This could be accounted for by first, the fast cleavage of the disulfide bonds which are on the surface of the nano-particle (with constant time τ 1 = 5.6 min), and second, the slow cleavage of the disulfide bonds intricated inside the polymer coating the surface of the quantum dot, for which the Cy7Q quencher has to diffuse out of the PEGylated polymer shell in order to restore the fluorescence. The short time constant, τ 1 , is indeed similar to that obtained for the cleavage of disulfide bonds linking a fluorescence quencher and an organic cyanine dye in previously described molecular probes (5 to 7 min) [14] . 
CONCLUSIONS AND PERSPECTIVES
In conclusion, the construction of activatable probes based on quantum dot particles, inorganic-organic hybrid labels with optimized optical properties for in vivo imaging, has been undertaken. Commercial PEGylated QDs, ITK705 amino (PEG) quantum dots (Invitrogen), coated by long PEG chains for in vivo furtivity and bearing around 80-100 amino pending groups for further functionalization are used. Functionalization of 80% of the amino groups by the near infrared fluorescence inhibitors Cy7Q or QSY21 leads to more than 99% fluorescence quenching. Cleavable spacers X-L-S-S-L'-Cy7Q in which S-S is a disulfide bond cleavable by cell internalization, and X a thioacetate group for grafting onto ITK705 maleimido (PEG) modified quantum dots, have been synthesized. The functionalization of the QD by 12 -L-S-S-L'-Cy7Q cleavable spacers leads to more than 85% fluorescence inhibition, which can be recovered upon the cleavage of the disulfide bonds. The remaining maleimido pendant groups (around 50 to 60 functions) will be used in the future for the grafting of tumour-targeting and cell internalization driving ligands, such as the cRGD peptide [14] [15] [16] . The future merging of the optimized optical properties of quantum dots and the use of activatable probes is expected to improve the image contrast in fluorescence tumor imaging, and the detection sensitivity of tumor metastases in small animal models.
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